Chirag Vasavda
14PUBLICATIONS
85CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|Sep 30, 2025
Biliverdin reductase A is a major determinant of protective NRF2 signaling.Chirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery
|Jun 12, 2025
A metabolite-based resistance mechanism against malaria.Ana Figueiredo, Sonia Trikha Rastogi, Susana Ramos
|May 08, 2024
Phenome-wide identification of therapeutic genetic targets, leveraging knowledge graphs, graph neural networks, and UK Biobank data.Lawrence Middleton, Ioannis Melas, Chirag Vasavda
|Nov 16, 2022
Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes.Abhishek Nag, Ryan S Dhindsa, Jonathan Mitchell
|Aug 03, 2022
Identification of the NRF2 transcriptional network as a therapeutic target for trigeminal neuropathic pain.Chirag Vasavda, Risheng Xu, Jason Liew
|May 10, 2022
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling.Chirag Vasavda, Evan R Semenza, Jason Liew
Pageof 3
Frequent Collaborators
6 joint publications
Ryan S Dhindsa
4 joint publications
Solomon H Snyder
4 joint publications
Bindu D Paul
3 joint publications
Xinzhong Dong
2 joint publications
Shawn G Kwatra
2 joint publications
Michael D Kornberg
2 joint publications
Evan R Semenza
2 joint publications
Jason Liew
2 joint publications
Slavé Petrovski
2 joint publications
Dimitrios Vitsios
